Pharmacy Report Archives - Page 3 of 153 - Becker's Hospital Review

FDA flags major GLP-1 compounder | The retail pharmacy business case | Off-label GLP-1 use surges 15-fold | 1st multi-cancer blood test nears FDA review | Fla. sues drugmakers, PBMs over insulin prices

Plus: 250 best healthcare employers: Forbes September 23, 2026 1. How to build the financial case for a new retail pharmacy Full story 2. FDA flags sterility concerns at major GLP-1 compounder Full story 3. Spend three days with the…

The pharmacy chiefs at the top children's hospitals | Can GLP-1s lead to blindness? | Novo's 5+ planned blockbuster drugs | Lilly taking 70% of new Medicare GLP-1 patients | 2 countries supply 90% of new drug ingredient

Plus: Ohio hospital pharmacy expands access to specialty infusions September 22, 2026 1. Meet the pharmacy chiefs of US News’ top 11 children’s hospitals Full story 2. GLP-1s and blindness: 6 things to know Full story 3. The future of pharmacy:…

Every state to join CMS Medicaid drug pricing model | The $10B expired drug problem | Where do medication errors occur most? | Pfizer to share overseas drug revenue with HHS | Lung cancer drug doubles survival in trial

@media only screen and (max-width: 600px) { table[width=”1″], table[style*=”width:600px”] { width: 100% !important; max-width: 100% !important; } img { max-width: 100% !important; height: auto !important; } .rightsection, .rightsection table { width: 100% !important; } p span[style*=”font-size:20px”] { font-size: 16px !important;…

Inside the nation's 1st age-friendly pharmacy | 9 GLP-1 updates to know | 12 pharmacies sue Express Scripts | Fairview 1st to deploy pharmacy robot | 10 systems hiring pharmacy leaders

Plus: 20 recent rural health funding distributions September 17, 2026 1. Inside the nation’s first age-friendly pharmacy Full story 2. 9 GLP-1 updates to know Full story 3. Cleveland Clinic, AdventHealth, and Cincinnati Children’s just joined Latent Health’s pharmacy intelligence…

Immediate jeopardy lifted at Ascension St. Thomas | Cost Plus Marketplace goes dark | CHOP names inaugural CPO | ASHP heads to Capitol Hill | FDA OKs breakthrough muscle disease drug

Plus: 70% of Gen Z healthcare workers eye the exit September 16, 2026 1. Immediate jeopardy lifted at Ascension St. Thomas Hospital after pharmacy error Full story 2. Cost Plus Marketplace goes dark after software outage Full story 3. More than…

5 new drugs in shortage | 3 injectable drugs recalled | FDA weighs psychedelic drugs | Tylenol maker, pharma giants renew autism legal battle | 8 systems in the black

Plus: AstraZeneca COPD drug delivers 2 phase 3 wins September 15, 2026 1. 5 new drugs in shortage Full story 2. 3 injectable drugs recalled after 9 adverse event reports Full story 3. Spend three days with the pharmacy leaders…

J&J's 340B ultimatum | What's next for Medicare's GLP-1 program? | US drug supply chain gets $16M boost | RWJBarnabas taps CPO | Novartis heart drug fails

Plus: One of the ‘most frequently reported health concerns’ in the US: What to know September 14, 2026 1. J&J to hospitals: Submit claims data or lose 340B pricing Full story 2. Medicare’s GLP-1 program is ‘far exceeding’ expectations, but a…

2 Ascension hospitals face Medicare termination after drug error | 100% of cancer centers report drug shortages: Survey | 10 systems hiring pharmacy leaders | The most expensive conditions hospitals treat | Novo wins Ozempic, Wegovy injunction

Plus: Pancreatic cancer drug shows promise in lung cancer September 10, 2026 1. Two Ascension hospitals face possible Medicare termination after pharmacy error Full story 2. 100% of cancer centers surveyed have 1 drug in shortage: 6 notes Full story…

FDA warns of compounded GLP-1 risks | 4 breakthrough therapies to watch | Lung disease drug posts record results | Can an AI drug slow aging? | Startup offers GLP-1s for addiction

Plus: 1 system’s response to Medicaid changes September 9, 2026 1. 4 breakthrough therapies pharmacy departments should prepare for now Full story 2. FDA warns clinicians on compounded GLP-1s amid 1,700+ safety reports Full story 3. Most conferences give pharmacy…

Ascension medication safety officer exits | FDA OKs 1st-of-its-kind breast cancer treatment | Why US patients are traveling to China for CAR-T | 3 epinephrine lots recalled | GLP-1 use surges among children

Plus: FDA boosts estradiol patch supply September 8, 2026 1. Ascension’s medication safety officer exits Full story 2. China becoming CAR-T destination for US patients: WSJ Full story 3. More than 500 pharmacy leaders and 150-plus speakers convene in Chicago…